INAVOLISIB

670 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking INAVOLISIB:

# Side effect Count
0 HYPERGLYCAEMIA 160
1 DIARRHOEA 100
2 BLOOD GLUCOSE INCREASED 93
3 FATIGUE 67
4 NAUSEA 65
5 NEUTROPENIA 48
6 STOMATITIS 43
7 WHITE BLOOD CELL COUNT DECREASED 39
8 DECREASED APPETITE 34
9 DIABETIC KETOACIDOSIS 34
See all common reactions for INAVOLISIB

INAVOLISIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SCALLOPED TONGUE 1 0.0333
1 ATROPHIC GLOSSITIS 3 0.0275
2 CHEMOTHERAPEUTIC DRUG LEVEL ABOVE THERAPEUTIC 1 0.0161
3 RETINAL DEGENERATION 16 0.0123
4 POSTMENOPAUSE 1 0.0086
5 MALIGNANT NEOPLASM OF PLEURA 1 0.0081
6 BLOOD BRAIN BARRIER DEFECT 1 0.0066
7 HYPERGLYCAEMIA 160 0.0044
8 FUNGAL PHARYNGITIS 1 0.0040
9 BONE CANCER METASTATIC 2 0.0038
See all enriched reactions for INAVOLISIB